Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
about
MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting BimComplement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancerNovel drugs targeting the epidermal growth factor receptor and its downstream pathways in the treatment of colorectal cancer: a systematic reviewLoss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.Robustness of signal transduction pathways.Targeting MAPK pathway in melanoma therapy.Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions.Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.High-throughput sequencing of the melanoma genome.The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
P2860
Q28118859-BC3E865D-5641-4963-9FBF-55513400E34FQ34615593-8D9901E2-8948-4F78-8152-E3FDCF507E9BQ36337063-BD1C3EFE-558B-4DC0-BE58-0E2964C0DB0CQ37060963-0F3DBFDD-5A94-4D3E-B020-E0FE00FEDFDAQ38046128-BBDCA323-AE00-45BD-B6DF-CE418382D14CQ38098888-2600EF20-FB38-43E1-BDBB-710874E49B3AQ38123513-13FC730B-3C86-4260-93AE-B472CA7AD1D5Q39035993-8AB1A9E9-486F-4C8B-9511-0CAF091D9502Q42773490-552C8F14-7387-40DF-8BF0-EC6E3431A4D0Q49364393-35488B99-9E44-4EDB-921D-3790E98D237DQ57156789-5B8BAECC-7D46-4AC0-9F01-50D0994D7D08
P2860
Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
@en
Selumetinib
@nl
type
label
Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
@en
Selumetinib
@nl
prefLabel
Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
@en
Selumetinib
@nl
P2860
P1476
Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
@en
P2093
Kevin B Kim
Sapna P Patel
P2860
P304
P356
10.1517/13543784.2012.665871
P407
P577
2012-03-07T00:00:00Z